This paper is in the following e-collection/theme issue:

JMH Theme Issue: COVID-19 and Mental Health: Impact and Interventions (383) JMIR Theme Issue: COVID-19 Special Issue (2452) Outbreak and Pandemic Preparedness and Management (1727) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517) Digital Biomarkers and Digital Phenotyping (191) Wearable Devices and Sensors (888) Substance Abuse (419)

Published on in Vol 7, No 10 (2020): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/21814, first published .
Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic

Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic

Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic

Authors of this article:

Michael Hsu1 Author Orcid Image ;   David K Ahern2 Author Orcid Image ;   Joji Suzuki3 Author Orcid Image
Article Authors Cited by (30) Tweetations (7) Metrics

Michael Hsu   1 , MD ;   David K Ahern   2 , PhD ;   Joji Suzuki   3 , MD

1 Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States

2 Digital Behavioral Health and Informatics Research Program, Brigham and Women's Hospital, Boston, MA, United States

3 Division of Addiction Psychiatry, Brigham and Women's Hospital, Boston, MA, United States

Corresponding Author:

  • Michael Hsu, MD
  • Department of Psychiatry
  • Brigham and Women's Hospital
  • 75 Francis Street
  • Boston, MA, 02115
  • United States
  • Phone: 1 617-732-5000
  • Email: mhsu7@partners.org